Autopsy report · NCT00118196

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

“Due to limited resources available to conduct study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months after it had already started.
• Ran for about 1 year 4 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Medical University of South Carolina

Sponsor type

University, hospital or other

Conditions

Leukemia; Myelodysplastic Syndromes

Interventions

arsenic trioxide; azacitidine

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• HBOT Late Radiation Tissue Injury
  “Lack of resources to complete the study” (78% match in meaning)
• Noninvasive NAVA Versus NIPPV in Low Birthweight Premature Infants
  “Insufficient resources available to complete the study” (77% match in meaning)
• RescueTEE for In-hospital Cardiac Arrest (ReTEECA Trial)
  “Not enough resources to execute study” (75% match in meaning)
• Home-based SSP on Individuals With PWS
  “Insufficient resources to complete study as planned” (75% match in meaning)
• Mindfulness in Medical Training
  “Not enough resources to proceed with the study” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.